
    
      This study is a randomized clinical effectiveness trial for patients at clinical high risk
      for psychosis that compares two treatments: 1) specialty care delivered in a specialized
      clinical for patients at clinical high risk for psychosis versus 2) treatment as usual in the
      community.
    
  